|
GB1116196A
|
|
Indole derivative and the preparation thereof
|
|
GB1092978A
|
|
Novel analgesic and antipyretic medicinal compositions
|
|
GB1065910A
|
|
Purified extracts of gleditsia species and compositions thereof
|
|
GB1047919A
|
|
Morpholine derivative, preparation thereof and compositions containing same
|
|
GB1119836A
|
|
Pharmaceutical compositions containing basic ethers
|
|
ES313015A2
|
|
Procedure for conditioning and presentation of pharmaceutical products. (Machine-translation by Google Translate, not legally binding)
|
|
GB1078759A
|
|
New form for compositions having anorexic action
|
|
GB1119835A
|
|
Process for the preparation of basic ethers
|
|
DE1470281A1
|
|
Pharmaceutically active nicotinic acid phenol esters and processes for their preparation
|
|
GB1084431A
|
|
Improvements in and relating to lipases
|
|
GB1040278A
|
|
Bacterial compositions for the regeneration of the intestinal microflora
|
|
ES288649A1
|
|
Procedure for conditioning and representation of pharmaceutical products (Machine-translation by Google Translate, not legally binding)
|
|
GB1040627A
|
|
New arginine derivatives for the treatment of hyperammoniaemia
|
|
GB1028815A
|
|
Amine salts
|
|
GB957769A
|
|
A substituted benzamide and pharmaceutical compositions containing it
|
|
GB964232A
|
|
Substituted benzamides and pharmaceutical compositions containing them
|
|
CA809667A
|
|
METHO-SULFATE D'.alpha.-PHENYL-.beta.-THIENYL-MORPHOLINO ETHYL-CARBINOL
|
|
CA749983A
|
|
Pharmaceutical compositions comprising an arganine compound
|
